FDA

ChemGenex Shares Takes a Hit due to Misunderstanding


ChemGenex Pharmaceuticals (CXS), an Australia based biotechnology research and development company that develops leukemia drugs stated that the latest difficulties faced by the company with the Food and Drug Administration (FDA) is only another hurdle in the drug approval process, although the traders provided the ChemGenex stocks with a right old shellacking.

Syndicate content

Recommended Websites